Mirion (NYSE: MIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, today announced that it will host an Investor Day on Tuesday, December 3, 2024, beginning at 2:00 p.m. ET. The event will be held at the New York Stock Exchange and webcast live.

Due to limited capacity, in-person attendance is by invitation only. Institutional investors and financial analysts wishing to attend in-person should contact ir@mirion.com before in-person registration closes on Monday, November 18, 2024. Interested parties can register for the live webcast at https://mirion-investor-day.open-exchange.net/. A link to the live webcast will also be available on the Mirion Investor Relations website at ir.mirion.com.

The event will feature presentations by members of Mirion’s leadership team, including:

• Thomas Logan, CEO, discussing the Company’s strategy and growth through radiation safety expertise;
• Brian Schopfer, CFO, sharing Mirion’s financial outlook and value creation strategy;
• Loic Eloy, President of the Technologies Group, presenting an overview of the Technologies Group and its innovations supporting the nuclear renaissance;
• Luis Rivera, EVP of the Medical Group, highlighting the Medical Group’s role in the growth of cancer care.

Formal presentations will be followed by a question-and-answer session.

To stay up to date on the latest information, visit the Mirion investor website at ir.mirion.com.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241024617980/en/